ArticleCureus2026

Performance Assessment of μTASWako i50, a New Microfluidic Immunoassay System for Hepatocellular Carcinoma Biomarkers AFP, AFP-L3%, and PIVKA-II.

Tomoyasu Yoshikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.